Mandate

Vinge advises EQT X in connection with its investment in HVD Group and Next One Technology

Vinges advises the EQT X fund (or “EQT Private Equity”) in connection with its investment in the Nordic software companies HVD Group (Hantverksdata) and Next (Next One Technology). Both companies serve the tradespeople and construction industry, with HVD Group focused on installation and service professions – such as electricians, plumbers, heating and ventilation firms – while Next is focused on contractors. HVD Group’s platform complements that of Next, and the investment thus paves the way for a further strengthened product offering, which builds on both companies’ strong customer satisfaction scores.

EQT Private Equity will invest in HVD Group and Next together with the existing HVD Group shareholder Adelis, who will increase its investment in the new combined company.

Both transactions are expected to close in February 2024.

Vinge’s team consisted of Christina Kokko, Karl Klackenberg, Elsie Nassar, Amanda Steen, Maximilian Bengtsson and Jonatan Stentorp (M&A), Louise Brorsson Salomon and Jolinn Uhlin (Financing), Marcus Glader, Daniel Wendelsson, Sebastian Örndahl, David Olander and Adam Löfquist (Regulatory), Axel Lennartsson (IPR), Mathilda Persson, Jolene Reimerson, Lisa Hörnqvist and Mario Saad (IT / GDPR), Christoffer Nordin, Carl Lexenberg and Arthur Kinski (Agreements), Emil Lindwall and Victor Björkheim (Employment) and Emelie Schoning (Transaction Support Coordinator).

Read the client's press release

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025